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Recurrent lower respiratory infections in infancy represent
a major health problem because of their high incidence and
possible consequences on lung function (1, 2). On the basis
of data acquired from a recent epidemiological study
carried out in Italy on 18 737 children aged 6–7 years,
lifetime pneumonia in 1999 showed a 7?9% frequency
(SIDRIA project, unpublished data).
Several environmental risk factors have been associated
with lower respiratory infections, but knowledge about
genetic predisposition is very limited (3). Analysis of
polymorphic genes involved in regulation of the immune
system is disclosing promising perspectives. In parti-
cular, chemokines and their receptors are involved in
host inflammatory response against invading pathogens
(4).
Chemokines are a family of pro-inflammatory cytokines
that attract and activate specific types of leukocytes (5).
Their actions are mediated by subfamilies of G-protein-
coupled receptors, indicated as CCR or CXCR (6). A
common 32-bp deletion in the CCR5 gene (CCR5D32) and
a G-to-A nucleotide substitution in the CCR2 gene at
position 190 (CCR264I) have been described (7, 8). These
variant alleles have been first associated with resistance to
HIV-1 infection and delay in the progression to AIDS (9–
12). Recently, their involvement has been investigated in
asthma, allergic diseases and insulin-dependent diabetes
mellitus (13–15).
Since CCR2 and CCR5 allelic forms have an important
role in regulating the immune response during the
infectious process we evaluated the distribution of these
genetic polymorphisms in children with recurrent respira-
tory tract infections.Received 27 September 2000 and accepted in revised form 21
February 2001.
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Case selection was made by means of strict clinical criteria
regarding lower respiratory infections: we enrolled Cauca-
sian children less than 7 years old (mean age: 4?6 years)
showing more than three episodes of low tract respiratory
infection per year, for at least 2 years. A total of 180
genomic DNA samples were analysed, including 50
children (60% males, 40% females) that met the selection
criteria and 130 controls selected from the general popula-
tion after excluding the presence of asthma or recurrent
respiratory infections. It was excluded the presence of cystic
fibrosis patients or mutation carriers by clinical evaluation
or reverse hybridization analysis. After obtaining informed
written consent, a mouthwash sample was taken for DNA
extraction, and CCR2 and CCR5 genotypes were deter-
mined on amplification products, as previously described
(16). Fisher’s exact test and w2 test were employed in order
to evaluate differences in allelic counts between cases and
controls and verify the Hardy–Weinberg equilibrium in
both groups.
Results and discussion
We observed a different distribution of CCR264I mutation
between cases and controls. The allelic frequency of
CCR264I mutant allele was 0?2 for cases and 0?07 for
controls, respectively, showing a statistically significant
difference among the two groups (P=0?001).
CCR2 and CCR5 genotypes and allelic frequencies in the
whole study population are summarized in Table 1. We
found that 20 (40%) out of 50 cases were classified as
heterozygous CCR2/CCR264I, whereas the remaining 30
cases (60%) were homozygous for the wild-type allele.
Among controls, 17 (13?1%) of 130 subjects were hetero-
zygous CCR2/CCR264I, 112 (86?1%) were homozygous
CCR2/CCR2 and 1 (0?8%) of 130 controls was found to be
homozygous CCR264I/CCR264I.
The following CCR5 genotype distribution was observed
among cases: 46 (92%) of 50 cases were homozygous for
CCR5 wild-type allele and four cases (8%) were hetero-
zygous CCR5/CCR5D32, with a 0?04 frequency of# 2001 HARCOURT PUBLISHERS LTD
TABLE 1. CCR2 and CCR5 allelic frequencies
Cases Controls
CCR2 CCR2/CCR2 30 (60%) 112 (86?1%)
Genotypes CCR2/CCR264I 20 (40%) 17 (13?1%)
CCR264I/CCR264I 0 1 (0?8%)
CCR2 CCR2 0?8 0?93
alleles CCR264I 0?2 0?07
CCR5 CCR5/CCR5 46 (92%) 120 (92?3%)
genotypes CCR5/CCR5D32 4 (8%) 9 (6?9%)
CCR5D32/CCR5D32 0 1 (0?8%)
CCR5 CCRD 0?96 0?96
alleles CCR5D32 0?04 0?04
CCR ALLELES IN RESPIRATORY INFECTIONS 431CCR5D32 allele. Among controls, 120 (92?3%) of 130
subjects were homozygous CCR5/CCR5, nine (6?9%) were
heterozygous CCR5/CCR5D32 and one (0?8%) was found
to be homozygous CCR5D32/CCR5D32, with a 0?04
frequency of CCR5 mutant allele. CCR5 allelic counts
did not show statistically significant difference between
cases and controls (P=0?8). CCR5D32 allelic frequency in
the general population was in accordance with previous
reports (16, 17). Both CCR2 and CCR5 genotype distribu-
tion were in equilibrium according to the Hardy–Winberg
equation.
CCR-family genes play a critical role in modulating
the immune response and acting as viral co-receptors (18).
On the basis of our preliminary results, a significantly
higher frequency of CCR264I allele has been observed in
children with recurrent respiratory tract infections, suggest-
ing a possible role in determining individual susceptibility.
Larger studies are in progress and further investigation will
contribute to clarify biological mechanisms and verify the
predictive value of CCR alleles.
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